LncRNA FEZF1-AS1 promotes pulmonary fibrosis via up-regulating EZH2 and targeting miR-200c-3p to regulate the ZEB1 pathway
Open Access
- 30 October 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-17
Abstract
The role and detailed mechanisms of lncRNAs in idiopathic pulmonary fibrosis (IPF) are not fully understood. qPCR was conducted to verify lncRNA FEZF1-AS1 expression in the transforming growth factor-beta 1 (TGF-β1)-stimulated human lung fibroblasts (HLF) and A549. The EMT-related proteins were performed by western blotting. Cell proliferation, migration, and transition were detected by CCK-8, colony formation, wound-healing and transwell assays. A dual-luciferase reporter assay was conducted to validate the target relationship of FEZF1-AS1 and miR-200c-3p. FEZF1-AS1 is highly expressed in the fibrotic A549 and HLF. in vitro experiments revealed that FEZF1-AS1 facilitates cell proliferation, migration and invasion. Knockdown of FEZF1-AS1 attenuated TGF-b1-induced fibrogenesis both in vitro. Moreover, silencing FEZF1-AS1 inhibited fibrogenesis through modulation of miR-200c-3p. In addition, inhibition of miR-200c-3p promoted fibrogenesis by regulation of Zinc finger E-box binding homeobox 1 (ZEB1). Mechanistically, FEZF1-AS1 promoted lung fibrosis by acting as a competing endogenous RNA (ceRNA) for miR-200c-3p. FEZF1-AS1 silencing increased the expression and activity of miR-200c-3p to inhibit ZEB1 and alleviate lung fibrogenesis in A549 and HLF. In addition, our study showed that FEZF1-AS1 can regulate enhancer of zeste homolog2 (EZH2) to upregulate fibrosis-related proteins and promote lung fibrosis. In summary, the results of our study revealed the pulmonary fibrogenic effect of FEZF1-AS1 in cellular experiments, demonstrating the potential roles and mechanisms of the FEZF1-AS1/miR-200c-3p/ZEB1 and FEZF1-AS1/EZH2 pathways, which provides a novel and potential therapeutic target to lung fibrosis.Keywords
Funding Information
- National Natural Science Foundation of China (82205079, 82205079, 82205079, 82205079)
- Natural Science Foundation of Shandong Province (ZR2023QH061, ZR2023QH061, ZR2023QH061, ZR2023QH061)
- Clinical research project of Affiliated Hospital of Weifang Medical College, Shandong Province, China (2022wyfylcyj05, 2022wyfylcyj05, 2022wyfylcyj05, 2022wyfylcyj05)
- Weifang Municipal Health Commission Traditional Chinese Medicine Research Project (WFZYY2024-4-004, WFZYY2024-4-004, WFZYY2024-4-004, WFZYY2024-4-004)
This publication has 43 references indexed in Scilit:
- miRNAs derived from plasma small extracellular vesicles predict organo-tropic metastasis of gastric cancerGastric Cancer, 2022
- Long non-coding RNA SNHG1 promotes fibroblast-to-myofibroblast transition during the development of pulmonary fibrosis induced by silica particles exposureEcotoxicology and Environmental Safety, 2021
- Bidirectional epithelial–mesenchymal crosstalk provides self-sustaining profibrotic signals in pulmonary fibrosisJournal of Biological Chemistry, 2021
- Human bronchial epithelial cell‐derived extracellular vesicle therapy for pulmonary fibrosis via inhibition of TGF‐β‐WNT crosstalkJournal of Extracellular Vesicles, 2021
- Upregulation of miR-200c-3p induced by NaF promotes endothelial apoptosis by activating Fas pathwayEnvironmental Pollution, 2020
- miRNA‐200c‐3p promotes endothelial to mesenchymal transition and neointimal hyperplasia in artery bypass graftsThe Journal of Pathology, 2020
- Hypoxia-induced lncRNA RP11-390F4.3 promotes epithelial-mesenchymal transition (EMT) and metastasis through upregulating EMT regulatorsCancer Letters, 2020
- Exogenous angiotensin (1-7) directly inhibits epithelial-mesenchymal transformation induced by transforming growth factor-β1 in alveolar epithelial cellsBiomedicine & Pharmacotherapy, 2019
- Long non‐coding RNA FEZF1‐AS1 promotes breast cancer stemness and tumorigenesis via targeting miR‐30a/Nanog axisJournal of Cellular Physiology, 2018
- Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expressionBiochemical and Biophysical Research Communications, 2016